A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

PHASE4TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 13, 2022

Study Completion Date

January 13, 2022

Conditions
Multiple Sclerosis
Interventions
DRUG

ACTHAR Gel (ACTH)

15 days of daily injections

DRUG

IV methylprednisolone (steroids)

3 days of intravenous methylprednisolone followed by 11 days of oral taper

Trial Locations (2)

19104

University of Pennsylvania Scheie Eye Institute, Philadelphia

80045

University of Colorado Denver, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

collaborator

University of Pennsylvania

OTHER

lead

University of Colorado, Denver

OTHER

NCT01838174 - A Trial of Neuroprotection With ACTH in Acute Optic Neuritis | Biotech Hunter | Biotech Hunter